Search Results - "WOHLRAB, Johannes"
-
1
Expression and activity of IL-17 receptor subunits in human cutaneous cells as targets for anti-IL-17 therapeutic antibodies
Published in Biomedicine & pharmacotherapy (01-02-2022)“…The key players in different chronic inflammatory skin diseases are cytokines belonging to the IL-17 group, IL-17 receptors and a T helper cell population,…”
Get full text
Journal Article -
2
Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs
Published in Dermatology and therapy (01-08-2024)“…Introduction Today, the approval for a generic topical product includes the presentation of therapeutic equivalence to the originator based on clinical trials…”
Get full text
Journal Article -
3
Potential Applications of Phyto-Derived Ceramides in Improving Epidermal Barrier Function
Published in Skin pharmacology and physiology (01-01-2017)“…The outer most layer of the skin, the stratum corneum, consists of corneocytes which are coated by a cornified envelope and embedded in a lipid matrix of…”
Get more information
Journal Article -
4
Hyperhidrosis: A Central Nervous Dysfunction of Sweat Secretion
Published in Dermatology and therapy (01-02-2023)“…Hyperhidrosis (HH) is a central nervous dysfunction characterized by abnormally increased sweating due to a central dysregulation of sweat secretion. HH…”
Get full text
Journal Article -
5
Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells
Published in PloS one (24-05-2011)“…Omeprazole has recently been described as a modulator of tumour chemoresistance, although its underlying molecular mechanisms remain controversial. Since…”
Get full text
Journal Article -
6
Does human leukocyte elastase degrade intact skin elastin?
Published in The FEBS journal (01-11-2012)“…This study aimed to investigate the susceptibility of intact fibrillar human elastin to human leukocyte elastase and cathepsin G. Elastin is a vital protein of…”
Get full text
Journal Article -
7
Etoricoxib-induced toxic epidermal necrolysis: Successful treatment with infliximab
Published in Journal of dermatology (01-10-2010)Get full text
Journal Article -
8
Treatment of a Clinically Relevant Plant-Pathogenic Fungus with an Agricultural Azole Causes Cross-Resistance to Medical Azoles and Potentiates Caspofungin Efficacy
Published in Antimicrobial Agents and Chemotherapy (01-10-2007)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
9
Methodological aspects of measuring absolute values of membrane potential in human cells by flow cytometry
Published in Cytometry. Part A (01-07-2009)“…The bis-barbituric acid oxonol, DiBAC₄(3) is used as a standard potentiometric probe in human cells. However, its fluorescence depends not only on membrane…”
Get full text
Journal Article -
10
Influence of keratolytics on cutaneous pharmacokinetics of glucocorticoids
Published in Journal der Deutschen Dermatologischen Gesellschaft (01-04-2021)“…Summary Background: Keratolytics are often used to accelerate and improve the therapeutic response of hyperkeratotic dermatoses. Keratolytics are a chemically…”
Get full text
Journal Article -
11
Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS
Published in Analytical and bioanalytical chemistry (01-10-2005)“…The ceramides of the stratum corneum are critical to maintaining the epidermal barrier function of the skin. A number of skin diseases and disorders are known…”
Get full text
Journal Article -
12
Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin
Published in Archives of Dermatological Research (01-05-2005)“…Ceramides are sphingolipids consisting of sphingoidbases, which are amide-linked to fatty acids. In the stratum corneum, they represent the major constituent…”
Get full text
Journal Article -
13
Pharmacology of inhibitors of Janus kinases – Part 1: Pharmacokinetics
Published in Journal der Deutschen Dermatologischen Gesellschaft (01-11-2022)“…Summary The use of Janus kinase inhibitors for the treatment of chronic inflammatory diseases is increasingly establishing itself as a treatment option for…”
Get full text
Journal Article -
14
Einfluss von Keratolytika auf die kutane Pharmakokinetik von Glukokortikoiden
Published in Journal der Deutschen Dermatologischen Gesellschaft (01-04-2021)Get full text
Journal Article -
15
Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin
Published in Histochemistry and cell biology (01-03-2008)“…In the present study, we characterized the distribution of human cationic amino acid transporters 1 (hCAT1) and 2 (hCAT2) in healthy skin and compared it to…”
Get full text
Journal Article -
16
Topical preparations and their use in dermatology
Published in Journal der Deutschen Dermatologischen Gesellschaft (01-11-2016)“…Summary The challenges of everyday clinical routine require dermatologists to have a basic knowledge of the composition of topical preparations as well as the…”
Get full text
Journal Article -
17
Persistent erythema and edema of the midthird and upper aspect of the face (morbus morbihan): Evidence of hidden immunologic contact urticaria and impaired lymphatic drainage
Published in Journal of the American Academy of Dermatology (01-04-2005)“…A persistent erythema and edema of the midthird and upper aspect of the face, which bears some resemblance to Melkersson-Rosenthal syndrome and rosaceous…”
Get full text
Journal Article -
18
Niacinamide - mechanisms of action and its topical use in dermatology
Published in Skin pharmacology and physiology (01-01-2014)“…Niacinamide, an amide of vitamin B3 (niacin), is a hydrophilic endogenous substance. Its effects after epicutaneous application have long been described in the…”
Get more information
Journal Article -
19
Pharmakologie der Januskinase-Inhibitoren - Teil 2: Pharmakodynamik: Pharmacology of inhibitors of Janus kinases - Part 2: Pharmacodynamics
Published in Journal der Deutschen Dermatologischen Gesellschaft (01-12-2022)“…Als niedermolekulare Substanzen haben die Januskinase-Inhibitoren unterschiedliche, dosisabhängige pharmakologische Bindungsselektivitäten, die allerdings…”
Get full text
Journal Article -
20
Pharmacology of inhibitors of Janus kinases – Part 2: Pharmacodynamics
Published in Journal der Deutschen Dermatologischen Gesellschaft (01-12-2022)“…Summary As small molecules, the Janus kinase inhibitors have different, dose‐dependent pharmacological binding selectivities, which, however, do not allow…”
Get full text
Journal Article